Target intelligence / Profile preview

Sortilin-related VPS10 domain containing receptor 2 (SorCS2)

Target
SorCS2
Molecular classification
Receptor, Type I transmembrane glycoprotein receptor, VPS10 domain family protein (vacuolar protein sorting 10 protein family)
01

Overview

SorCS2 (Sortilin-related VPS10 domain containing receptor 2) is a member of the VPS10 protein family, primarily expressed in the central nervous system, especially in neurons. It is a type I transmembrane glycoprotein receptor with a single transmembrane pass, a large extracellular domain containing a characteristic Vps10p domain (beta-propeller structure), and a leucine-rich repeat domain. SorCS2 acts as a multiligand receptor, binding various neurotrophic factors, amyloid precursor protein, and cytokines, thereby participating in cellular signaling and trafficking. It is crucial for neuronal viability, synaptic plasticity, and is differentially processed in neurons versus glial cells, leading to tissue-specific effects. Genetic variants in SorCS2 are associated with several psychiatric and neurodegenerative disorders, as well as differential severity in alcohol withdrawal. If specific information is required for structured drug interactions or mechanism details, further data mining is needed since current results list function and disease association, but no named clinical agents.

Other names
SorCS2KIAA1329VPS10 domain-containing receptor SorCS2sortilin related VPS10 domain containing receptor 2
02

Mechanism of action

Drugs targeting SorCS2 would potentially modulate neurotrophic factor signaling, endocytosis, synaptic plasticity, and may affect interactions with NGFR, BDNF (proBDNF), and related neurotrophins.

03

Biological functions

Cell signaling (multiligand receptor, can bind neurotrophic factors, amyloid precursor protein, cytokines)Neuronal viability, synaptic plasticity, dendritic spine density regulation, neurite branching/extensionCellular trafficking and endocytosisApoptosis regulation in glial cellsModulation of synapse depression and potentiation (in complex with neurotrophin receptors)
04

Disease associations

Neuropsychiatric disorders (association with ADHD, bipolar disorder, schizophrenia)Neurodegenerative diseases (Alzheimer's disease)Alcohol withdrawal severityType 2 diabetes (receptor family association)Deafness, Autosomal Recessive 51 and Nemaline Myopathy 7 (GeneCards annotation)
05

Safety considerations

Modulation may impact neuronal viability and plasticity, potentially exacerbating neuropsychiatric or neurodegenerative disease if misregulatedProapoptotic effects in glial cells depending on molecular processingDisease risk haplotypes associated with severe alcohol withdrawal
06

Interacting drugs

No approved drugs appear directly listed as interacting with SorCS2; however, other VPS10 domain family members interact with PDGF-BB and NGF. Mechanistic research compounds may exist but are not explicitly named in the search.
07

Biomarkers

SNPs and risk haplotypes in SorCS2 gene (used to associate with alcohol withdrawal risk and psychiatric disorders)Expression levels may serve as biomarkers for some neuropsychiatric conditions

Beyond the preview

Go deeper on Sortilin-related VPS10 domain containing receptor 2 (SorCS2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sortilin-related VPS10 domain containing receptor 2 (SorCS2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call